Author

O. A. Carpaij

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:host-pathogen & immune response· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

M. C. Nawijn· 2 shared M. van den Berge· 2 shared A. Cvejic· 1 shared A. J. van Oosterhout· 1 shared B. M. ter Ellen· 1 shared B. Troost· 1 shared C.-A. Brandsma· 1 shared D. P. I. van de Pol· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

M. C. Nawijn

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Moxidectin and ivermectin inhibit SARS-CoV-2 replication in Vero E6 cells but not in human primary airway epithelium cells

N. Dinesh Kumar, B. M. ter Ellen, E. M. Bouma, B. Troost, D. P. I. van de Pol, H. H. van der Ende-Metselaar, D. van Gosliga, L. Apperloo, O. A. Carpaij, M. van den Berge, M. C. Nawijn, Y. Stienstra, I. A. Rodenhuis-Zybert, J. Smit

This study compares the antiviral activity of moxidectin and ivermectin against SARS-CoV-2 in Vero E6 cells and human airway epithelial cells, finding inhibition in Vero cells but not in human cells.

bioRxiv · May 17, 2021Microbiology

A cellular census of healthy lung and asthmatic airway wall identifies novel cell states in health and disease

F. A. Vieira Braga, G. Kar, M. Berg, O. A. Carpaij, K. Polanski, L. M. Simon, S. Brouwer, T. Gomes, L. Hesse, J. Jiang, E. S. Fasouli, M. Efremova, R. Vento-Tormo, K. Affleck, S. Palit, , S. A. Teichmann

The paper uses single-cell transcriptomics to identify novel cell states in healthy and asthmatic lung tissues, revealing changes in cell communication and immune responses.

bioRxiv · Jan 23, 2019 · PreprintImmunology